Le Lézard
Classified in: Health, Science and technology
Subject: PDT

FDA Clears nView Medical's First Imaging System, nView s1


SALT LAKE CITY, July 13, 2019 /PRNewswire-PRWeb/ -- nView medical Inc. (nView) today announced the U.S. Food and Drug Administration (FDA) clearance of nView s1, the company's first imaging system, bringing breakthrough imaging technology to surgery.

nView's mission is to make surgery safer, faster, and consistently accurate by creating instant 3D information throughout the surgical procedure. nView s1 integrates the latest developments in low-dose x-ray imaging with intelligent imaging algorithms to provide fluoroscopic and multiplanar views derived from tomographic reconstructions. These views can be used by surgeons to accurately assess the anatomy and placement of implants during spinal and orthopedic procedures.

"nView s1 is an imaging platform that provides invaluable information to surgeons throughout the procedure. The technology can be used intraoperatively to visualize the surgery and at the end of the procedure to confirm the quality of the surgery. The future of surgery will be enabled by automation and quantification. nView s1 is our first step in that direction" said Cristian Atria, founder and CEO at nView medical.

Lisa Last, COO, commented: "nView s1 has been cleared as a fluoroscopic and tomographic imaging system for adult and pediatric populations. In pediatrics, our low-dose operation brings a unique opportunity to increase precision via 3D imaging while minimizing radiation exposure. The 510(k) clearance will allow us to expand our work with research partners in pilot sites".

About nView
nView medical, based in Salt Lake City, UT, is an early stage start-up whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Consortium for Pediatric Device Innovation, MedtechInnovator, Dr. Kevin Foley, MD, and Fusion Fund (Palo Alto, CA).

 

SOURCE nView medical


These press releases may also interest you

at 09:51
Since the outset of the COVID-19 pandemic, the Government of Canada has used the latest science and evidence to inform our response. By collaborating with scientists and experts, we are ensuring the provinces and territories have the tools they need...

at 09:30
Optimi Health Corp. ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that it has filed a preliminary prospectus (the "Preliminary...

at 09:30
The Biometric Technology Market is Segmented by Type (Based on physical characteristics, Based on behavioral characteristics), by Application (Public sector, Banking & financial sector, Healthcare, IT & telecommunication), by Regions & Key players...

at 09:30
The "Surgical Instruments Market (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. According to the findings of a study by the University of California, Irwin Medical Center, hip and knee replacement surgeries are on the rise...

at 09:25
According to Coherent Market Insights, the global vascular patches market is estimated to be valued at US$ 4,778.33 million in 2020 and is expected to exhibit a CAGR of 7.0% during the forecast period (2020-2027). Key Trends and Analysis of the...

at 09:25
Peachtree Corners ? the nation's first smart city environment powered by real-world infrastructure and next-generation connectivity ? announced the addition of revolutionary artificial intelligence-powered camera technology from Cawamo at City Hall ?...



News published on 13 july 2019 at 16:00 and distributed by: